Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 COVID-19 Vaccines
1.2.3 COVID-19 Therapeutics
1.3 Market by Application
1.3.1 Global COVID-19 Vaccines & Therapeutics Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Vaccines & Therapeutics Market Perspective (2018-2033)
2.2 COVID-19 Vaccines & Therapeutics Growth Trends by Region
2.2.1 Global COVID-19 Vaccines & Therapeutics Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 COVID-19 Vaccines & Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Vaccines & Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 COVID-19 Vaccines & Therapeutics Market Dynamics
2.3.1 COVID-19 Vaccines & Therapeutics Industry Trends
2.3.2 COVID-19 Vaccines & Therapeutics Market Drivers
2.3.3 COVID-19 Vaccines & Therapeutics Market Challenges
2.3.4 COVID-19 Vaccines & Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Vaccines & Therapeutics Players by Revenue
3.1.1 Global Top COVID-19 Vaccines & Therapeutics Players by Revenue (2018-2023)
3.1.2 Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Vaccines & Therapeutics Revenue
3.4 Global COVID-19 Vaccines & Therapeutics Market Concentration Ratio
3.4.1 Global COVID-19 Vaccines & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Vaccines & Therapeutics Revenue in 2023
3.5 COVID-19 Vaccines & Therapeutics Key Players Head office and Area Served
3.6 Key Players COVID-19 Vaccines & Therapeutics Product Solution and Service
3.7 Date of Enter into COVID-19 Vaccines & Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Vaccines & Therapeutics Breakdown Data by Type
4.1 Global COVID-19 Vaccines & Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Type (2024-2033)
5 COVID-19 Vaccines & Therapeutics Breakdown Data by Application
5.1 Global COVID-19 Vaccines & Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
6.2 North America COVID-19 Vaccines & Therapeutics Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023)
6.4 North America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
7.2 Europe COVID-19 Vaccines & Therapeutics Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023)
7.4 Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
9.2 Latin America COVID-19 Vaccines & Therapeutics Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023)
9.4 Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer COVID-19 Vaccines & Therapeutics Introduction
11.1.4 Pfizer Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Moderna Therapeutics
11.2.1 Moderna Therapeutics Company Detail
11.2.2 Moderna Therapeutics Business Overview
11.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Introduction
11.2.4 Moderna Therapeutics Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.2.5 Moderna Therapeutics Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Introduction
11.3.4 AstraZeneca Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Janssen
11.4.1 Janssen Company Detail
11.4.2 Janssen Business Overview
11.4.3 Janssen COVID-19 Vaccines & Therapeutics Introduction
11.4.4 Janssen Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.4.5 Janssen Recent Development
11.5 Novavax
11.5.1 Novavax Company Detail
11.5.2 Novavax Business Overview
11.5.3 Novavax COVID-19 Vaccines & Therapeutics Introduction
11.5.4 Novavax Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.5.5 Novavax Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Detail
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Introduction
11.6.4 Gilead Sciences Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.6.5 Gilead Sciences Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Introduction
11.7.4 Eli Lilly and Company Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023)
11.7.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of COVID-19 Vaccines
Table 3. Key Players of COVID-19 Therapeutics
Table 4. Global COVID-19 Vaccines & Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 5. Global COVID-19 Vaccines & Therapeutics Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global COVID-19 Vaccines & Therapeutics Market Share by Region (2018-2023)
Table 8. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global COVID-19 Vaccines & Therapeutics Market Share by Region (2024-2033)
Table 10. COVID-19 Vaccines & Therapeutics Market Trends
Table 11. COVID-19 Vaccines & Therapeutics Market Drivers
Table 12. COVID-19 Vaccines & Therapeutics Market Challenges
Table 13. COVID-19 Vaccines & Therapeutics Market Restraints
Table 14. Global COVID-19 Vaccines & Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global COVID-19 Vaccines & Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top COVID-19 Vaccines & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)
Table 17. Ranking of Global Top COVID-19 Vaccines & Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by COVID-19 Vaccines & Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players COVID-19 Vaccines & Therapeutics Product Solution and Service
Table 21. Date of Enter into COVID-19 Vaccines & Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global COVID-19 Vaccines & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global COVID-19 Vaccines & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global COVID-19 Vaccines & Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global COVID-19 Vaccines & Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 32. North America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 35. Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 38. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer COVID-19 Vaccines & Therapeutics Product
Table 49. Pfizer Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Moderna Therapeutics Company Detail
Table 52. Moderna Therapeutics Business Overview
Table 53. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product
Table 54. Moderna Therapeutics Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Moderna Therapeutics Recent Development
Table 56. AstraZeneca Company Detail
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca COVID-19 Vaccines & Therapeutics Product
Table 59. AstraZeneca Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Janssen Company Detail
Table 62. Janssen Business Overview
Table 63. Janssen COVID-19 Vaccines & Therapeutics Product
Table 64. Janssen Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Janssen Recent Development
Table 66. Novavax Company Detail
Table 67. Novavax Business Overview
Table 68. Novavax COVID-19 Vaccines & Therapeutics Product
Table 69. Novavax Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Novavax Recent Development
Table 71. Gilead Sciences Company Detail
Table 72. Gilead Sciences Business Overview
Table 73. Gilead Sciences COVID-19 Vaccines & Therapeutics Product
Table 74. Gilead Sciences Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Gilead Sciences Recent Development
Table 76. Eli Lilly and Company Company Detail
Table 77. Eli Lilly and Company Business Overview
Table 78. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product
Table 79. Eli Lilly and Company Revenue in COVID-19 Vaccines & Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Eli Lilly and Company Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Vaccines & Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global COVID-19 Vaccines & Therapeutics Market Share by Type: 2023 VS 2033
Figure 3. COVID-19 Vaccines Features
Figure 4. COVID-19 Therapeutics Features
Figure 5. Global COVID-19 Vaccines & Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global COVID-19 Vaccines & Therapeutics Market Share by Application: 2023 VS 2033
Figure 7. Children Case Studies
Figure 8. Adult Case Studies
Figure 9. COVID-19 Vaccines & Therapeutics Report Years Considered
Figure 10. Global COVID-19 Vaccines & Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global COVID-19 Vaccines & Therapeutics Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 12. Global COVID-19 Vaccines & Therapeutics Market Share by Region: 2023 VS 2033
Figure 13. Global COVID-19 Vaccines & Therapeutics Market Share by Players in 2023
Figure 14. Global Top COVID-19 Vaccines & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Vaccines & Therapeutics as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by COVID-19 Vaccines & Therapeutics Revenue in 2023
Figure 16. North America COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 18. United States COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 22. Germany COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific COVID-19 Vaccines & Therapeutics Market Share by Region (2018-2033)
Figure 30. China COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 38. Mexico COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa COVID-19 Vaccines & Therapeutics Market Share by Country (2018-2033)
Figure 42. Turkey COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia COVID-19 Vaccines & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 45. Moderna Therapeutics Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 47. Janssen Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 48. Novavax Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 49. Gilead Sciences Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 50. Eli Lilly and Company Revenue Growth Rate in COVID-19 Vaccines & Therapeutics Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed